OBJECTIVES: The aim of this study is to determine the prevalence of psychosis in mild cognitive impairment (MCI, Petersen's criteria) and patients with Alzheimer's dementia, and to characterize the associated behavioral and psychological signs and symptoms of dementia (BPSD). METHOD: A cross-sectional analysis of baseline data from an ongoing, prospective, longitudinal study on BPSD was performed, including 270 MCI and 402 AD patients. BPSD assessment was performed through Middelheim Frontality Score (MFS), Behave-AD, Cohen-Mansfield Agitation Inventory (CMAI) and Cornell Scale for Depression in Dementia (CSDD). Psychosis was considered to be clinically relevant when delusions and/or hallucinations occurred at least once in the last two weeks prior to the BPSD assessment. RESULTS: The prevalence of psychosis in AD (40%) was higher than in MCI (14%; p < 0.001). AD patients with psychosis showed more severe frontal lobe, BPSD, agitation and depressive symptoms (MFS, Behave-AD, CMAI and CSDD total scores), whereas MCI patients with psychosis only showed more severe frontal lobe and physically non-aggressive agitated behavior. In addition, only in psychotic AD patients, all BPSD and types of agitation were more severe compared to non-psychotic AD patients. Comparing MCI and AD patients, MCI patients with psychosis did not show more severe frontal lobe, behavioral and psychological (Behave-AD), depressive symptoms or agitation than AD patients without psychosis. CONCLUSION: AD patients clearly display psychosis associated BPSD, whereas MCI patients only display more severe frontal lobe symptoms and physically non-aggressive agitated behavior, but also less pronounced than in AD.
OBJECTIVES: The aim of this study is to determine the prevalence of psychosis in mild cognitive impairment (MCI, Petersen's criteria) and patients with Alzheimer's dementia, and to characterize the associated behavioral and psychological signs and symptoms of dementia (BPSD). METHOD: A cross-sectional analysis of baseline data from an ongoing, prospective, longitudinal study on BPSD was performed, including 270 MCI and 402 ADpatients. BPSD assessment was performed through Middelheim Frontality Score (MFS), Behave-AD, Cohen-Mansfield Agitation Inventory (CMAI) and Cornell Scale for Depression in Dementia (CSDD). Psychosis was considered to be clinically relevant when delusions and/or hallucinations occurred at least once in the last two weeks prior to the BPSD assessment. RESULTS: The prevalence of psychosis in AD (40%) was higher than in MCI (14%; p < 0.001). ADpatients with psychosis showed more severe frontal lobe, BPSD, agitation and depressive symptoms (MFS, Behave-AD, CMAI and CSDD total scores), whereas MCI patients with psychosis only showed more severe frontal lobe and physically non-aggressive agitated behavior. In addition, only in psychotic ADpatients, all BPSD and types of agitation were more severe compared to non-psychotic ADpatients. Comparing MCI and ADpatients, MCI patients with psychosis did not show more severe frontal lobe, behavioral and psychological (Behave-AD), depressive symptoms or agitation than ADpatients without psychosis. CONCLUSION:ADpatients clearly display psychosis associated BPSD, whereas MCI patients only display more severe frontal lobe symptoms and physically non-aggressive agitated behavior, but also less pronounced than in AD.
Authors: Alain D Dekker; Silvia Sacco; Angelo Carfi; Bessy Benejam; Yannick Vermeiren; Gonny Beugelsdijk; Mieke Schippers; Lyanne Hassefras; José Eleveld; Sharina Grefelman; Roelie Fopma; Monique Bomer-Veenboer; Mariángeles Boti; G Danielle E Oosterling; Esther Scholten; Marleen Tollenaere; Laura Checkley; André Strydom; Gert Van Goethem; Graziano Onder; Rafael Blesa; Christine Zu Eulenburg; Antonia M W Coppus; Anne-Sophie Rebillat; Juan Fortea; Peter P De Deyn Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Tobi Van den Bossche; Kristel Sleegers; Elise Cuyvers; Sebastiaan Engelborghs; Anne Sieben; Arne De Roeck; Caroline Van Cauwenberghe; Steven Vermeulen; Marleen Van den Broeck; Annelies Laureys; Karin Peeters; Maria Mattheijssens; Mathieu Vandenbulcke; Rik Vandenberghe; Jean-Jacques Martin; Peter P De Deyn; Patrick Cras; Christine Van Broeckhoven Journal: Neurology Date: 2016-04-01 Impact factor: 9.910
Authors: Jonas J de Paula; Maicon R Albuquerque; Guilherme M Lage; Maria A Bicalho; Marco A Romano-Silva; Leandro F Malloy-Diniz Journal: Braz J Psychiatry Date: 2016-04-08 Impact factor: 2.697
Authors: Farid Chekani; Holly M Holmes; Michael L Johnson; Hua Chen; Jeffrey T Sherer; Rajender R Aparasu Journal: Drug Healthc Patient Saf Date: 2020-01-31